OMLEYA
Live / Applied — Fourth extension granted (statement of use) (as of 18 Nov 2025)
What this means for you
Not registered yet, but its 25 May 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98012789
- Mark type
- Stylized text
- Filed
- 25 May 2023
- Published for opposition
- 17 Oct 2023
- Attorney of record
- Kelley B. Harrington
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of endothelial diseases and disorders, renal diseases, transplant complications, ischemia-reperfusion injury and hematological, autoimmune, neurological, immunological and inflammation-related disease and disorders; biologics for the treatment of endothelial diseases and disorders, renal diseases, transplant complications, ischemia-reperfusion injury and hematological, autoimmune, neurological, immunological and inflammation-related disease and disorders
Owner
- Omeros Corporation, Seattle, WA, US
- Omeros Corporation, Seattle, WA, US
Prosecution history
- 18 Nov 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 18 Nov 2025 — SOU EXTENSION 4 GRANTED
- 17 Nov 2025 — SOU EXTENSION 4 FILED
- 17 Nov 2025 — SOU TEAS EXTENSION RECEIVED
- 08 Apr 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 08 Apr 2025 — SOU EXTENSION 3 GRANTED
- 07 Apr 2025 — SOU EXTENSION 3 FILED
- 07 Apr 2025 — SOU TEAS EXTENSION RECEIVED
- 14 Nov 2024 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 14 Nov 2024 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 14 Nov 2024 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 14 Nov 2024 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 14 Nov 2024 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 14 Nov 2024 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 17 Oct 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED